Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 14 of 864 for:    LENALIDOMIDE AND Angiogenesis

Salvage Treatment With Lenalidomide and Dexamethaosne (LEN-DEX) in Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00786851
Recruitment Status : Completed
First Posted : November 6, 2008
Last Update Posted : August 17, 2016
Sponsor:
Collaborator:
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte
Information provided by (Responsible Party):
Fondazione Italiana Linfomi ONLUS